Apoglyx Competitors and Similar CompaniesClear all
Apoglyx's competitors and similar companies include BIOTON and Enthera Pharmaceuticals.
 Apoglyx Apoglyx is a biotech company developing a small molecule oral therapy for type 2 diabetes patients. |  Enthera Pharmaceuticals Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication. | ||
Founding Date | Founding Date 2015 | Founding Date 1989 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private |
Tags | |||
Locations | Locations Malmö, SE HQ Lund, SE | Locations Macierzysz, PL HQ | Locations Milan, IT HQ Milan, IT Milan, IT |
Employees | Employees 525% increase | Employees 361 | Employees 225% increase |
For sources of this data, please see the company profile
View Company Profiles
BIOTON
HQ
Macierzysz, PL
Employees
361
Bioton is a biotech company whose major therapeutic area is diabetes.
View companyEnthera Pharmaceuticals
HQ
Milan, IT
Employees
22↑ 5% increase
Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication.
View company